Clinical uses of Bupropion in patients with Parkinson’s disease and comorbid depressive or neuropsychiatric symptoms: a scoping review

Abstract Objective Bupropion, an antidepressant inhibiting the reuptake of dopamine and noradrenaline, should be useful to treat depressive symptoms in patients with Parkinson’s disease (PD). Limited and conflicting literature data questioned its effectiveness and safety in depressed PD patients and...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Matteo Vismara, Beatrice Benatti, Gregorio Nicolini, Ilaria Cova, Edoardo Monfrini, Alessio Di Fonzo, Vincenza Fetoni, Caterina A. Viganò, Alberto Priori, Bernardo Dell’Osso
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	BMC 2022-05-01
Serie:	BMC Neurology
Soggetti:	Bupropion Parkinson’s disease Depression Neuropsychiatric symptoms Pharmacological treatment
Accesso online:	https://doi.org/10.1186/s12883-022-02668-4
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!